| 000 | 01810 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516215511.0 | ||
| 264 | 0 | _c20150730 | |
| 008 | 201507s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0099211 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHanafi, Laïla-Aïcha | |
| 245 | 0 | 0 |
_aFludarabine downregulates indoleamine 2,3-dioxygenase in tumors via a proteasome-mediated degradation mechanism. _h[electronic resource] |
| 260 |
_bPloS one _c2014 |
||
| 300 |
_ae99211 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtoxicity |
| 650 | 0 | 4 |
_aB7-H1 Antigen _xmetabolism |
| 650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
| 650 | 0 | 4 |
_aHistocompatibility Antigens Class I _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoleamine-Pyrrole 2,3,-Dioxygenase _xgenetics |
| 650 | 0 | 4 |
_aInterferon-gamma _xpharmacology |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aProteasome Endopeptidase Complex _xmetabolism |
| 650 | 0 | 4 | _aProtein Stability |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xmetabolism |
| 650 | 0 | 4 |
_aSTAT1 Transcription Factor _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aVidarabine _xanalogs & derivatives |
| 700 | 1 | _aGauchat, Dominique | |
| 700 | 1 | _aGodin-Ethier, Jessica | |
| 700 | 1 | _aPossamaï, David | |
| 700 | 1 | _aDuvignaud, Jean-Baptiste | |
| 700 | 1 | _aLeclerc, Denis | |
| 700 | 1 | _aGrandvaux, Nathalie | |
| 700 | 1 | _aLapointe, Réjean | |
| 773 | 0 |
_tPloS one _gvol. 9 _gno. 6 _gp. e99211 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0099211 _zAvailable from publisher's website |
| 999 |
_c23902234 _d23902234 |
||